"We're having a spike of flu definitely," Dr. Pilar Delgado told CBS News Miami.

The American Academy of Pediatrics has issued updated recommendations for RSV prevention in infants and high-risk young children.

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective ...

As an FDA official said that the agency has evidence that links COVID vaccines to the deaths of at least 10 children, the U.S ...

In this morning's Pharmalittle roundup, we're reading about FDA scrutiny of RSV therapies, an AI tool for clinical trials, ...

Among adults older adults, a respiratory syncytial virus (RSV) infection increases the risk of cardiovascular events over the ...

Federal regulators have begun a safety review of 2 RSV medicines used to protect infants, even though no safety problems have been reported.

Respiratory syncytial virus infection in adults aged 45 years or older is significantly associated with a higher 1-year risk ...

Respiratory syncytial virus, commonly known as RSV, is often associated with cold-like symptoms in young children. But a new ...

Health news and commentary gathered by MedPage Today staff ...

Early-life viral infection programs immune cells to hijack allergy-associated maternal antibodies, driving allergy risk later ...

Vaccination of pregnant women against respiratory syncytial virus is linked to a substantial reduction in infants' risk for ...